Wed, Aug 12, 2026

Bristol Myers Squibb picks Generation Park for $2.3B Houston plant

A Fortune 500 drugmaker picks a master-planned Houston park over a from-scratch site, and the site-selection math shows why.

Last verified · How we report · Report a correction

$2.3Binvestment
600K SFcampus size
500permanent jobs

Bristol Myers Squibb will build a $2.3 billion pharmaceutical manufacturing campus at Generation Park, McCord Development’s 4,300-acre master-planned hub in northeast Houston. The roughly 600,000-square-foot facility will produce small-molecule drugs, biologics and antibody-drug conjugates, and the company says it is designed as a modular, multi-modal campus that can add manufacturing lines as demand shifts rather than being built for a single product line.

Why it matters

For developers and GCs chasing life-sciences work, the site-selection choice is the story as much as the dollar figure. BMS did not build a from-scratch industrial park. It bought into an existing 4,300-acre master-planned development with entitlements, utilities and rail and highway access already in place, a pattern that favors landowners who control shovel-ready parcels inside established parks over raw greenfield sites. The deal also lands squarely in the industrial-manufacturing reshoring wave developers have been positioning for, with a Fortune 500 pharma name validating Houston as a life-sciences manufacturing location alongside its existing energy and petrochemical base. More: Houston →

The permits and deals moving the US. Free, every weekday.

The numbers

BMS is putting $2.3 billion into the campus, part of the company’s previously announced $40 billion, five-year commitment to U.S. research, technology and domestic manufacturing. The Houston project is expected to create nearly 500 permanent skilled jobs spanning operations, production, maintenance, engineering and quality control, plus approximately 2,000 construction and indirect jobs between 2027 and 2030. CEO Christopher Boerner said the investment “reflects our confidence in America’s continued leadership in biopharmaceutical innovation.”

What’s next

Construction is slated to run 2027 through 2030, with the campus scaling in phases after that as BMS brings additional manufacturing lines online. Watch for Harris County or state of Texas incentive filings tied to the project, and for whether Generation Park lands a second life-sciences tenant now that a name-brand pharma anchor has committed.

Quick answers

What is the latest on Generation Park?
Bristol Myers Squibb will build a $2.3B, 600,000-square-foot manufacturing campus at McCord Development's Generation Park in Houston.
Who is developing Generation Park?
McCord Development, according to Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas (BMS Newsroom).
What are the key numbers for Generation Park?
investment: $2.3B; campus size: 600K SF; permanent jobs: 500.

On the record

BMS's own release ties the Generation Park campus to its broader $40 billion, five-year U.S. manufacturing and R&D commitment, and puts construction and indirect employment at roughly 2,000 jobs between 2027 and 2030, on top of the nearly 500 permanent roles the trade coverage led with.

Public record · news.bms.com

Also reported by

How we report →

Next storyVeritas and Refound Buy 257 Utah Apartments in 3 DealsVeritas Investments and Refound Residential bought three mid-rise apartment communities, 257 units, in Salt Lake City and Ogden, per Northmarq.
Newsletter

Get the AmDev Daily Index

One free briefing every weekday morning.